July 8, 2026 · Form 4 insider transaction
Carver Kyle bought 1,000 shares of Evommune, Inc. at $13.26 per share, a transaction worth $13.3K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 2 days after the transaction.
The purchase by the reporting person reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934 with the sales of 1,000 shares of the Issuer's common stock by the reporting person at the price of $23.42 per share on May 28, 2026. The reporting person has agreed to pay to the Issuer upon settlement of the purchase, $10,160, representing the full amount of the profit realized in connection with the short-swing transaction.